Coyle Financial Counsel LLC Veru Inc. Transaction History

Coyle Financial Counsel LLC

  • $408 Million
  • Q3 2025

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 14, 2025
SELL
$0.49 - $0.7 $192 - $274
-392 Reduced 3.39%
11,165 $6,000
Q1 2025

May 01, 2025
BUY
$0.45 - $1.28 $176 - $501
392 Added 3.51%
11,557 $5,000
Q3 2024

Nov 08, 2024
BUY
$0.77 - $1.04 $897 - $1,211
1,165 Added 11.65%
11,165 $8,000
Q4 2023

Feb 15, 2024
BUY
$0.67 - $1.17 $6,700 - $11,700
10,000 New
10,000 $7,000

Others Institutions Holding VERU

# of Institutions
20
Shares Held
9M
Call Options Held
0
Put Options Held
32.7K
View Full List

About VERU INC.

VERU Quotes by TradingView
  • Ticker VERU
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 80,146,704
  • Market Cap $204M
  • Description
  • Veru Inc., an oncology biopharmaceutical company, focuses on developing medicines for the management of cancers. Its commercial products comprise FC2 female condom/internal condom for the dual protection against unintended pregnancy and the transmission of sexually transmitted infections for ministries of health, government health agencies, U.N....
More about VERU
Track This Portfolio

Track Coyle Financial Counsel LLC Portfolio

Follow Coyle Financial Counsel LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Coyle Financial Counsel LLC, based on Form 13F filings with the SEC.

News

Stay updated on Coyle Financial Counsel LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email